I agree that this site is using cookies. You can find further informations here.
X
Haq, Rizwan
578  results:
Search for persons X
?
1

A next-generation BRAF inhibitor overcomes resistance to BR..:

Yaeger, Rona ; McKean, Meredith A. ; Haq, Rizwan...
Cancer Discovery.  , 2024
Link: https://doi.org/10.1158/..
 
?
2

A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523)..:

Buchbinder, Elizabeth I. ; Cohen, Justine V. ; Tarantino, Giuseppe...
Cancer Research Communications.  4 (2024)  5 - p. 1321-1327 , 2024
Link: https://doi.org/10.1158/..
 
?
3

Somatic structural variants drive distinct modes of oncogen..:

Conway, Jake R. ; Gillani, Riaz ; Crowdis, Jett...
Journal of Clinical Investigation.  134 (2024)  13 - p. , 2024
Link: https://doi.org/10.1172/..
 
?
4

A phase I/II study of LY3022855 with BRAF/MEK inhibition in..:

Buchbinder, Elizabeth I. ; Giobbie-Hurder, Anita ; Haq, Rizwan.
Investigational New Drugs.  41 (2023)  4 - p. 551-555 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Phase 1b study of intravenous coxsackievirus A21 (V937) and..:

Lutzky, Jose ; Sullivan, Ryan J. ; Cohen, Justine V....
Journal of Cancer Research and Clinical Oncology.  149 (2023)  9 - p. 6059-6066 , 2023
Link: https://doi.org/10.1007/..
 
?
6

Characterizing metastatic uveal melanoma patients who devel..:

Wei, Alexander Z. ; Uriel, Matan ; Porcu, Agata...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
7

Adapted to Survive: Targeting Cancer Cells with BH3 Mimetic:

Montero, Joan ; Haq, Rizwan
Cancer Discovery.  12 (2022)  5 - p. 1217-1232 , 2022
Link: https://doi.org/10.1158/..
 
?
8

Integrative clinical and molecular characterization of tran..:

Bakouny, Ziad ; Sadagopan, Ananthan ; Ravi, Praful...
Cell Reports.  38 (2022)  1 - p. 110190 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Characterization of genetics in patients with mucosal melan..:

Buchbinder, Elizabeth I. ; Weirather, Jason L. ; Manos, Michael...
Cancer Medicine.  10 (2021)  8 - p. 2627-2635 , 2021
Link: https://doi.org/10.1002/..
 
?
10

Cytokine changes during immune-related adverse events and c..:

Tyan, Kevin ; Baginska, Joanna ; Brainard, Martha...
Cancer Immunology, Immunotherapy.  70 (2021)  8 - p. 2209-2221 , 2021
Link: https://doi.org/10.1007/..
 
?
11

Combining CTLA-4 and angiopoietin-2 blockade in patients wi..:

Ott, Patrick A ; Nazzaro, Matthew ; Pfaff, Kathleen L...
Journal for ImmunoTherapy of Cancer.  9 (2021)  11 - p. e003318 , 2021
Link: https://doi.org/10.1136/..
 
?
12

Tumor and immune reprogramming during immunotherapy in adva..:

Bi, Kevin ; He, Meng Xiao ; Bakouny, Ziad...
Cancer Cell.  39 (2021)  5 - p. 649-661.e5 , 2021
Link: https://doi.org/10.1016/..
 
?
13

Efficacy and Safety of Novel Formulation of Clobetasol Prop..:

Sidgiddi, Srinivas ; Naqvi, Syed Mujtaba Hussain ; Shenoy, Manjunath...
Dermatology and Therapy.  11 (2021)  5 - p. 1717-1732 , 2021
Link: https://doi.org/10.1007/..
 
?
14

Vitamin D intake is associated with decreased risk of immun..:

Grover, Shilpa ; Dougan, Michael ; Tyan, Kevin...
Cancer.  126 (2020)  16 - p. 3758-3767 , 2020
Link: https://doi.org/10.1002/..
 
?
15

Clinical landscape of oncolytic virus research in 2020:

Macedo, Nicholas ; Miller, David M ; Haq, Rizwan.
Journal for ImmunoTherapy of Cancer.  8 (2020)  2 - p. e001486 , 2020
Link: https://doi.org/10.1136/..
 
1-15